182 related articles for article (PubMed ID: 33296812)
1. SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells.
Wang N; Weng J; Xia J; Zhu Y; Chen Q; Hu D; Zhang X; Sun R; Feng J; Minato N; Gong Y; Su L
Stem Cell Res; 2020 Dec; 49():102099. PubMed ID: 33296812
[TBL] [Abstract][Full Text] [Related]
2. A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells.
Ma Y; Weng J; Wang N; Zhang Y; Minato N; Su L
Int J Biol Macromol; 2021 Jun; 180():718-728. PubMed ID: 33753200
[TBL] [Abstract][Full Text] [Related]
3. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.
Zhang Y; Gong Y; Hu D; Zhu P; Wang N; Zhang Q; Wang M; Aldeewan A; Xia H; Qu X; Ring BZ; Minato N; Su L
Oncogene; 2015 Mar; 34(11):1451-62. PubMed ID: 24704834
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
Hsieh SM; Smith RA; Lintell NA; Hunter KW; Griffiths LR
BMC Cancer; 2009 Sep; 9():331. PubMed ID: 19765277
[TBL] [Abstract][Full Text] [Related]
5. A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer.
Guo L; Zhang W; Zhang X; Wang J; Nie J; Jin X; Ma Y; Wang S; Zhou X; Zhang Y; Xu Y; Tanaka Y; Yuan J; Liao XH; Gong Y; Su L
Oncogene; 2023 Aug; 42(35):2641-2654. PubMed ID: 37500797
[TBL] [Abstract][Full Text] [Related]
6. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells.
Ji K; Ye L; Toms AM; Hargest R; Martin TA; Ruge F; Ji J; Jiang WG
Cancer Genomics Proteomics; 2012; 9(5):321-7. PubMed ID: 22990111
[TBL] [Abstract][Full Text] [Related]
7. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.
Ugenskienė R; Myrzaliyeva D; Jankauskaitė R; Gedminaitė J; Jančiauskienė R; Šepetauskienė E; Juozaitytė E
Biomarkers; 2016; 21(4):363-70. PubMed ID: 26901824
[TBL] [Abstract][Full Text] [Related]
8. Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.
Pei R; Xu Y; Wei Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Front Med; 2013 Mar; 7(1):138-42. PubMed ID: 23358895
[TBL] [Abstract][Full Text] [Related]
9. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Takahara T; Kasamatsu A; Yamatoji M; Iyoda M; Kasama H; Saito T; Takeuchi S; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Exp Cell Res; 2017 Mar; 352(2):357-363. PubMed ID: 28237246
[TBL] [Abstract][Full Text] [Related]
10. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
11. Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.
Roberts MR; Hong CC; Edge SB; Yao S; Bshara W; Higgins MJ; Freudenheim JL; Ambrosone CB
Breast Cancer Res Treat; 2013 Jun; 139(3):873-85. PubMed ID: 23771732
[TBL] [Abstract][Full Text] [Related]
12. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
Park YG; Zhao X; Lesueur F; Lowy DR; Lancaster M; Pharoah P; Qian X; Hunter KW
Nat Genet; 2005 Oct; 37(10):1055-62. PubMed ID: 16142231
[TBL] [Abstract][Full Text] [Related]
13. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
14. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.
Yi SM; Li GY
Tumour Biol; 2014 Jan; 35(1):441-5. PubMed ID: 24006220
[TBL] [Abstract][Full Text] [Related]
15. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.
Crawford NP; Ziogas A; Peel DJ; Hess J; Anton-Culver H; Hunter KW
Breast Cancer Res; 2006; 8(2):R16. PubMed ID: 16563182
[TBL] [Abstract][Full Text] [Related]
16. Dynamic relationship between SIPA1 gene and protein expression and the development of gastric cancer.
Li JY; Wang JB; Liu CB; Ma DL; Ma JH
Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28362978
[TBL] [Abstract][Full Text] [Related]
17. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
Yeh HW; Hsu EC; Lee SS; Lang YD; Lin YC; Chang CY; Lee SY; Gu DL; Shih JH; Ho CM; Chen CF; Chen CT; Tu PH; Cheng CF; Chen RH; Yang RB; Jou YS
Nat Cell Biol; 2018 Apr; 20(4):479-491. PubMed ID: 29593326
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-2'-deoxycytidine advances the epithelial-mesenchymal transition of breast cancer cells by demethylating
Lu A; Wang W; Wang-Renault SF; Ring BZ; Tanaka Y; Weng J; Su L
J Cell Sci; 2020 May; 133(9):. PubMed ID: 32193333
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
Gaudet MM; Hunter K; Pharoah P; Dunning AM; Driver K; Lissowska J; Sherman M; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Int J Cancer; 2009 Apr; 124(7):1716-20. PubMed ID: 19089925
[TBL] [Abstract][Full Text] [Related]
20. [Reversal of stemness in multidrug-resistant hepatocellular carcinoma cells by SIS3].
Yan W; Wen T; Lin S; Liu Z; Yang W; Wu G
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):731-5. PubMed ID: 26813590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
